<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Low-dose aclarubicin (LDACR) therapy is one of the differentiation induction therapy, such as low-dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> therapy, 1 alpha, 25 dihydroxy-<z:chebi fb="0" ids="28940">vitamin D3</z:chebi> or <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> therapy, for <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and atypical <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A 36-year-old female with hypoplastic <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> was treated with this atypical <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>A 36-year-old female with hypoplastic <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> was treated with this LDACR therapy </plain></SENT>
<SENT sid="3" pm="."><plain>On admission, she was suffered from general <z:mp ids='MP_0002899'>fatigue</z:mp> and her peripheral blood smear showed <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> with 23% of myeloblasts </plain></SENT>
<SENT sid="4" pm="."><plain>Bone marrow examination revealed a moderately <z:e sem="disease" ids="C0151773" disease_type="Disease or Syndrome" abbrv="">hypoplastic marrow</z:e> with 35.4% of myeloblasts </plain></SENT>
<SENT sid="5" pm="."><plain>She was diagnosed as having hypoplastic <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Thereafter, 20 mg of aclarubicin was given daily by one-shot intravenous injection for 10 days </plain></SENT>
<SENT sid="7" pm="."><plain>After this LDACR therapy, myeloblasts disappeared from her peripheral blood and <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> improved </plain></SENT>
<SENT sid="8" pm="."><plain>Bone marrow examination showed increase in nuclear cell counts and she achieved complete remission </plain></SENT>
<SENT sid="9" pm="."><plain>In this article, we report the clinical course of this patient and discuss the effect of LDACR therapy as useful chemotherapy for this patient </plain></SENT>
</text></document>